Enjoy complimentary customisation on priority with our Enterprise License!
The direct-to-consumer genetic testing market size is forecast to increase by USD 1.22 billion, at a CAGR of 12.99% between 2023 and 2028.
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The direct-to-consumer (DTC) genetic testing market continues to evolve, driven by advancements in technology and shifting consumer preferences. Affiliate marketing plays a significant role in customer acquisition, while genetic counseling ensures accurate interpretation of results. Carrier screening and prenatal testing expand application areas, and marketing automation optimizes outreach. Influencer marketing boosts brand awareness, and UI/UX design enhances user experience. FDA regulations and HIPAA compliance ensure data security, with data integration enabling seamless analysis. AI and machine learning facilitate disease prediction and personalized medicine. E-commerce platforms streamline sales, and sample processing expedites turnaround time. Data visualization and report generation simplify results presentation.
SNP analysis, API integrations, and ce marking expand regulatory compliance. Lifetime value (LTV) optimization and GDPR compliance enhance customer retention. Newborn screening and clinical interpretation expand testing scope. A/B testing and machine learning-driven algorithm development improve marketing effectiveness. DNA extraction and saliva samples simplify testing methods. Laboratory services ensure accuracy and reliability. Email marketing and social media marketing broaden reach. Data security and data analysis are ongoing priorities. The market's continuous dynamism reflects the evolving needs of consumers and the industry.
The direct-to-consumer genetic testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The diagnostic screening segment is estimated to witness significant growth during the forecast period.
Direct-to-consumer genetic testing has gained significant traction in the healthcare industry, offering consumers insights into their inherited disease risks and predispositions. Market companies provide various tests, categorized as diagnostic screening and carrier screening. Diagnostic screening includes cancer predisposition tests, such as Myriad's myRisk Hereditary Cancer test, and genetic health risk tests for conditions like neurological disorders, diabetes, cardiovascular diseases (CVDs), and rare diseases, using advanced technologies like artificial intelligence and machine learning. Carrier screening tests determine if an individual carries specific genes linked to certain diseases, enabling them to make informed decisions regarding family planning. Marketing strategies, such as affiliate marketing, influencer marketing, and content marketing, are employed to boost customer acquisition.
User interface (UI) design and data integration ensure seamless testing kit ordering and data analysis processes. FDA regulations and HIPAA compliance are adhered to, ensuring data security and privacy. E-commerce platforms and software development facilitate the purchase and delivery of genetic testing kits. Digital marketing, including email marketing and social media marketing, help increase brand awareness and customer retention. Data visualization and report generation tools simplify complex genetic data for users. Turnaround time is a crucial factor, with many companies offering quick results. Direct-to-consumer genetic testing also includes ancestry testing, health risk assessments, and personalized medicine, catering to diverse consumer needs.
Data security and GDPR compliance are essential aspects, with companies implementing robust security measures and algorithms to protect user data. Innovations like mobile app development, API integrations, and lab services further enhance the user experience. Machine learning and clinical interpretation assist in accurate disease prediction and sample processing. The lifetime value of customers is maximized through effective customer retention strategies. In summary, the market is evolving, with a focus on providing accurate, accessible, and personalized genetic information to consumers. Market dynamics include advanced technologies, strategic marketing, and regulatory compliance, ensuring a positive impact on the healthcare industry and individual well-being.
The Diagnostic screening segment was valued at USD 633.50 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 38% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Direct-to-consumer genetic testing services in the US are experiencing significant growth due to increasing consumer demand for early disease diagnosis and pre-market authorization. Chronic diseases, such as cancer and diabetes, which are prevalent in the region, fuel this demand. In response, industry companies continually innovate, offering new genetic testing services, including those that enable consumers to discuss their health status with healthcare professionals for appropriate guidance. Marketing strategies, such as affiliate marketing, influencer marketing, and content marketing, are essential for customer acquisition. User interface design, data integration, and data analysis are critical components of these services.
FDA regulations and HIPAA compliance are stringent, necessitating software development and digital marketing expertise. Direct-to-consumer genetic testing kits, which include saliva or blood samples, are integrated with e-commerce platforms and laboratory services for sample processing and clinical interpretation. Turnaround time is a crucial factor, with mobile apps, machine learning, and artificial intelligence used to expedite results. GDPR compliance and data security are essential considerations for data visualization and report generation. Personalized medicine, including disease prediction and health risk assessment, is a growing trend. APIs, SNP analysis, and CE marking are also integral parts of the industry.
Customer retention is achieved through email marketing, social media marketing, and customer service. Brand awareness is enhanced through various marketing channels. Newborn screening and carrier screening are additional services offered. In conclusion, the market in the US is dynamic, with a focus on innovation, regulatory compliance, and customer service. It offers significant opportunities for growth in various areas, including disease prediction, personalized medicine, and customer acquisition.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
In the burgeoning the market, individuals can now access personalized health insights from the comfort of their homes. This revolutionary sector blends technology, genetics, and consumer convenience. Companies offer tests for various traits, including ancestry, health predispositions, and carrier status. Genetic data is analyzed using advanced algorithms, providing customers with comprehensive reports. The market caters to diverse demographics, ensuring inclusivity. Consumers value the convenience, affordability, and accessibility of these tests. Privacy concerns, however, remain a significant issue, with data security being a top priority. The market continues to evolve, integrating telemedicine and artificial intelligence to enhance the user experience. As regulatory frameworks adapt, the market promises to revolutionize healthcare and personal wellness.
The direct-to-consumer genetic testing market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the direct-to-consumer genetic testing market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, direct-to-consumer genetic testing market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
23andMe Holding Co. - A groundbreaking genetic testing service identifies hereditary prostate cancer risk markers through direct-to-consumer tests, empowering individuals to take preventative measures against this disease.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Direct-To-Consumer Genetic Testing Market insights. See full methodology.
Market Scope |
|
Report Coverage |
Details |
Page number |
149 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.99% |
Market growth 2024-2028 |
USD 1219.3 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
11.25 |
Key countries |
US, China, Germany, UK, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this direct-to-consumer genetic testing market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Service
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.